1-2 of 2
Michele Nassin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase III, multicenter, randomized, placebo controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult sickle cell disease patients with frequent vaso-occlusive crises: The sparkle study

Free
Andrew Campbell, Ana Silva-Pinto, Obiageli Nnodu, Deepa Manwani, Deborah Keefe, Jimmy Watson, Evgeniya Reshetnyak, Velusamy Muthusamy, Partha Banerjee, Olufolake Egbujo (Adisa), Michele Nassin, Yvonne Dei-Adomakoh
Journal: Blood
Blood (2025) 146 (Supplement 1): 1198.
https://doi.org/10.1182/blood-2025-1198
Published: 2025
Journal Articles

The Location of Genomic Breakpoints in AML1/RUNX1 and ETO in De Novo znd Therapy-Related Leukemia Patients sith T(8;21) Are Similar znd Colocalize with Topoisomerase II Cleavage Sites.

Free
Yanming Zhang, Neelmini Emmanuel, Nimanthi Jayathilaka, Heidi Gerr, Michele Nassin, Pamela Strissel, Reiner Strick, Nicole Dastugue, Bertil Johansson, Claudia Schoch, Susanne Schnittger, Brigitte Schlegelberger, Janet D. Rowley
Journal: Blood
Blood (2004) 104 (11): 1974.
https://doi.org/10.1182/blood.V104.11.1974.1974
Published: 2004